The Oxford Academic Health Science Network aims to break down traditional organisational boundaries and bring the NHS, universities, science and business closer together. To that end we have been inviting nominations for a new award acknowledging effective partnerships between the public sector and industry. A shortlist has now been drawn up and the winners will be announced at the OBN Annual Awards night on 2 October.
The shortlisted public-private collaborations are (in no particular order):
- Buckinghamshire Healthcare NHS Trust, University of Reading and University of Loughborough
Development of microcapillary film offering low-cost rapid testing of multiple biomarkers for a wide range of point-of-care diagnostic applications including acute cardiovascular disease and rapid microbial identification. The start-up company Capillary Film Technology Ltd has received funding from private investors, SBRI and other sources. More information here.
- Cranfield University and Bedford Hospital NHS Trust
What? ‘OsteoVibe’ – new vibration technology and clinical tool for diagnosis and monitoring of osteoporosis and bone fractures. OsteoVibe is a mobile, automatic, low-cost, radiation-free and reliable tool for early diagnosis in primary care. It can be used by a wide range of health professionals and in situations where other scans are impractical. It should lead to fewer hospital admissions.
- Buckinghamshire Healthcare NHS Trust and Janssen Healthcare
A new structured and tailored programme – Care4Today Heart Health Solutions – which has led to improved outcomes for cardiac rehabilitation patients and increased staff satisfaction. This project has also been shortlisted for a Health Service Journal Value in Healthcare Award. Winners will be announced on 23 September. Further information
- Isansys Lifecare Ltd
Technology giving early warning of sepsis in patients recovering at home following chemotherapy patients. This initiative received funding through SBRI. Sepsis is a more common cause of hospital admission than heart attack, often leads to death and costs the NHS approximately £20,000 per patient. Early detection and intervention in a vulnerable patient group saves lives and cuts costs. Further information here, here and here.